We are committed to finding a cure for WM.

Nov 27th is Giving Tuesday

In 2012, NYC’s 92nd Street Y and the United Nations Foundation partnered to establish a day to celebrate giving. After all the Black Friday sales and Thanksgiving feasts, Giving Tuesday is a reminder of the greatness of giving after a… Continue reading

Notes from the WMFC Halifax Ed Forum

The first-ever Waldenstrom’s Macroglobulinemia Foundation of Canada’s (WMFC) educational forum in Halifax, Nova Scotia on October 27 provided four dozen patients, family members and hematology nurses the opportunity to learn from and speak with international and local WM experts, and… Continue reading

October is Membership Month!


“When we work together we have the power to take problems head on and make a difference in our life and in the lives of others around us.”   
                                              David DeNotaris   
As the fall… Continue reading

Pivotal Trial Underway for Zanubrutinib in Waldenström Macroglobulinemia

Source: https://www.cancertherapyadvisor.com/hematologic-cancers/waldenstrom-macroglobulinemia-zanubrutinib-new-trial-treatment/article/801383/

A head-to-head, open-label, multicenter, phase 3 clinical trial comparing the efficacy and safety of zanubrutinib (BGB-3111) with ibrutinib in patients with Waldenström macroglobulinemia (WM) is underway (ClinicalTrials.org Identifier: NCT03053440).1 The study also seeks to evaluate the… Continue reading